MATTER OF FACT AWARDED U.S. PATENT FOR VITAMIN C STABILIZATION TECHNOLOGY

Setting a New Standard for Potency and Performance

LOS ANGELES, Sept. 9, 2025 /PRNewswire/ -- MATTER OF FACT has been granted a U.S. patent (US Patent No. 12,390,444) for its breakthrough method of solubilizing and stabilizing vitamin C (L-ascorbic acid) - marking a new breakthrough in the vitamin C category and a major leap forward in skincare research and innovation. With this latest grant, MATTER OF FACT now holds three issued patents with thirty-nine others pending worldwide.

Unlike most vitamin C formulas, which either rely on water as a major solvent and begin degrading within months, or are waterless but have a grainy texture due to the vitamin C crystals being suspended instead of dissolved, MATTER OF FACT's 20% Vitamin C BRIGHTENING + FIRMING SERUM is waterless and thus highly stable, fully solubilized and thus non-grainy, and clinically proven to be efficacious for at least two years, from first use to expiry.

Category-Defining Innovation
This newly patented technology prevents significant oxidation of L-ascorbic acid through a novel water-free solubilization process utilizing urea as a counterintuitive co-solvent, along with ferulic acid. While other vitamin C technologies have demonstrated various levels of stability, MATTER OF FACT's technology is the first and only vitamin C formula to demonstrate not only excellent stability, but also clinical efficacy at both the beginning and end of its shelf-life, solving one of skincare's most enduring formulation challenges. This innovation effectively succeeds the current industry gold standard vitamin C technology - and redefines what consumers can expect from their skincare.

Founder-Led Research & Development
Unlike many beauty patents outsourced to labs or third-party formulators, this technology was invented and written by MATTER OF FACT founder Paul Baek, a first-generation Korean-American and Harvard graduate. "We didn't just aim to stabilize vitamin C, we set out to redefine what's possible and reshape industry standards," said Paul Baek, Founder and Formulator of MATTER OF FACT. "While this patent is a milestone for our brand, it's also a turning point for the industry. It proves that independent brands can also contribute significant innovations and set new standards for what consumers can expect from their skincare."

An Innovation Milestone
Baek began developing the formula in 2018, when he experimented with solubilizing vitamin C without water. Following years of lab work and 3 clinical trials, his research was published in the Journal of Investigative Dermatology (2023) and presented at the International Societies for Investigative Dermatology (ISID) conference in Tokyo - where MATTER OF FACT became the first independent skincare brand to present.

The published research showed statistically significant improvements in signs of photoaging, even when tested on product close to its expiry date.

Today's announcement cements BRIGHTENING + FIRMING SERUM as a category-defining innovation and reinforces MATTER OF FACT's mission to push the skincare industry forward through rigorous research and results-driven formulation.

BRIGHTENING + FIRMING SERUM (SRP $102) is available at MATTEROFFACT.com, Sephora.com, Amazon.com, and select professional channels including CosmoprofBeauty.com.

About MATTER OF FACT
Founded by Paul Baek, MATER OF FACT is an advanced, innovation-driven skincare brand committed to delivering high-performance, clinically proven products backed by a portfolio of three granted patents globally, and a growing number of patent-pending technologies. The brand's dedication to transparency, efficacy, and innovation has earned it a reputation as a trusted name in the skincare industry. For more information, visit www.matteroffact.com

About Next8 Investments
Next8 Investments is a beauty incubator founded by industry disruptors Edward Connaghan and Denise Russell. The acclaimed entrepreneurs are known for their work on Olaplex and K18 Hair, and as brand architects behind Goddess Maintenance Co.'s Biotech Blowout. Focusing on biotechnology, they foster advancements in skin and hair care. Next8 Investments supports emerging beauty and biotech founders while pioneering technologies in human biology, AI, and genetics.

Follow MATTER OF FACT's journey at @matteroffact

For press inquiries please contact:
US: ICA, [email protected]

SOURCE MATTER OF FACT